PropertyValue
?:abstract
  • Increasing severity of ketoacidosis in newly diagnosed type 1 diabetes (T1D) has been reported during the coronavirus 2019 disease (COVID-19) pandemic in Germany[1] and cases of delayed presentation of children with T1D have also been reported in Italy[2] and the United States[3]. There are significant differences in healthcare delivery systems and socioeconomic status (SES) between the United States and Europe, prompting us to evaluate if delayed presentation can be documented in a large pediatric diabetes center in the United States.
?:creator
?:doi
  • 10.1111/dme.14461
?:doi
?:journal
  • Diabet_Med
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/4f3e58d1cadfa55afd7c6b31c837556de0fd279d.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7744830.xml.json
?:pmcid
?:pmid
?:pmid
  • 33236448.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • A trend towards an early increase in ketoacidosis at presentation of paediatric type 1 diabetes during the coronavirusā€2019 pandemic
?:type
?:year
  • 2020-12-01

Metadata

Anon_0  
expand all